Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis Antibodies | 1 | 2018 | 100 | 0.68 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.62 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.52 | Why? |
| Homosexuality, Male | 2 | 2018 | 1158 | 0.40 | Why? |
| Enterovirus D, Human | 2 | 2019 | 96 | 0.34 | Why? |
| Hepatitis B, Chronic | 3 | 2019 | 616 | 0.33 | Why? |
| Enterovirus Infections | 2 | 2019 | 404 | 0.26 | Why? |
| Hepatitis B virus | 3 | 2019 | 882 | 0.25 | Why? |
| Liver Cirrhosis | 3 | 2019 | 1810 | 0.24 | Why? |
| Hepatitis Delta Virus | 1 | 2019 | 54 | 0.20 | Why? |
| Hepatitis D | 1 | 2019 | 48 | 0.19 | Why? |
| Giardia lamblia | 1 | 2018 | 20 | 0.19 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.19 | Why? |
| Hepatitis B Surface Antigens | 2 | 2018 | 305 | 0.19 | Why? |
| DNA, Protozoan | 1 | 2018 | 77 | 0.18 | Why? |
| Giardiasis | 1 | 2018 | 34 | 0.18 | Why? |
| Lymphogranuloma Venereum | 1 | 2017 | 23 | 0.18 | Why? |
| Italy | 14 | 2021 | 38444 | 0.17 | Why? |
| Lamivudine | 1 | 2018 | 210 | 0.16 | Why? |
| Syphilis | 2 | 2018 | 318 | 0.16 | Why? |
| Bronchiolitis | 1 | 2021 | 297 | 0.16 | Why? |
| Lipopeptides | 1 | 2019 | 229 | 0.16 | Why? |
| Chlamydia trachomatis | 1 | 2017 | 172 | 0.16 | Why? |
| Tenofovir | 1 | 2019 | 449 | 0.15 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2018 | 403 | 0.14 | Why? |
| Aspergillus | 1 | 2018 | 347 | 0.14 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.13 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2020 | 11367 | 0.13 | Why? |
| Polyethylene Glycols | 1 | 2017 | 574 | 0.12 | Why? |
| Pulmonary Aspergillosis | 1 | 2018 | 408 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.12 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.11 | Why? |
| Influenza B virus | 1 | 2017 | 815 | 0.11 | Why? |
| Pregnancy Complications, Infectious | 3 | 2021 | 11559 | 0.11 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Mothers | 1 | 2021 | 1624 | 0.10 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.10 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2018 | 973 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2018 | 2149 | 0.09 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.08 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.08 | Why? |
| Infectious Disease Transmission, Vertical | 2 | 2021 | 5164 | 0.08 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.08 | Why? |
| Fever | 2 | 2021 | 7795 | 0.08 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.08 | Why? |
| Adult | 16 | 2021 | 244371 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.07 | Why? |
| Capsid Proteins | 2 | 2019 | 365 | 0.07 | Why? |
| Diarrhea | 1 | 2017 | 2743 | 0.07 | Why? |
| Phylogeny | 3 | 2019 | 13341 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.07 | Why? |
| Coinfection | 3 | 2019 | 6820 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.06 | Why? |
| Antiviral Agents | 4 | 2019 | 41703 | 0.06 | Why? |
| Female | 17 | 2021 | 380317 | 0.06 | Why? |
| Aged | 9 | 2020 | 215776 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Drug Therapy, Combination | 3 | 2019 | 7268 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Pregnancy Trimester, Third | 1 | 2021 | 445 | 0.05 | Why? |
| Humans | 24 | 2021 | 930598 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Sequence Analysis, DNA | 2 | 2019 | 2830 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2019 | 88759 | 0.05 | Why? |
| DNA, Viral | 3 | 2018 | 2521 | 0.05 | Why? |
| Hepatitis B Core Antigens | 1 | 2018 | 76 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Membranes, Artificial | 1 | 2000 | 175 | 0.05 | Why? |
| DNA, Fungal | 1 | 2018 | 95 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Proctitis | 1 | 2017 | 16 | 0.04 | Why? |
| Macrocyclic Compounds | 1 | 2018 | 78 | 0.04 | Why? |
| Maintenance Chemotherapy | 1 | 2018 | 133 | 0.04 | Why? |
| Biocompatible Materials | 1 | 2000 | 214 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Hospitals, University | 2 | 2021 | 4173 | 0.04 | Why? |
| Campylobacter | 1 | 2017 | 34 | 0.04 | Why? |
| Lactams, Macrocyclic | 1 | 2018 | 130 | 0.04 | Why? |
| Pregnancy Outcome | 2 | 2021 | 3803 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Anilides | 1 | 2018 | 105 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Hepatitis B e Antigens | 1 | 2017 | 99 | 0.04 | Why? |
| Hepatitis C | 2 | 2017 | 1514 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Causality | 1 | 2021 | 857 | 0.04 | Why? |
| Unsafe Sex | 1 | 2017 | 139 | 0.04 | Why? |
| Valine | 1 | 2018 | 359 | 0.04 | Why? |
| Sustained Virologic Response | 1 | 2018 | 378 | 0.04 | Why? |
| Proline | 1 | 2018 | 345 | 0.04 | Why? |
| Infant | 4 | 2021 | 30274 | 0.04 | Why? |
| Cyclopropanes | 1 | 2018 | 332 | 0.04 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.04 | Why? |
| Disease Outbreaks | 3 | 2019 | 27595 | 0.04 | Why? |
| Sequence Homology, Amino Acid | 1 | 2017 | 945 | 0.04 | Why? |
| Child | 6 | 2021 | 70012 | 0.03 | Why? |
| Pregnancy | 3 | 2021 | 23879 | 0.03 | Why? |
| Child Health Services | 1 | 2021 | 520 | 0.03 | Why? |
| Carbamates | 1 | 2018 | 485 | 0.03 | Why? |
| Nose | 1 | 2020 | 1093 | 0.03 | Why? |
| Rotavirus | 1 | 2017 | 329 | 0.03 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Molecular Sequence Data | 1 | 2019 | 3198 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Liver Function Tests | 1 | 2019 | 1325 | 0.03 | Why? |
| Patient Acuity | 1 | 2019 | 1755 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| Hepacivirus | 2 | 2018 | 1509 | 0.03 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.03 | Why? |
| Drug Monitoring | 1 | 2019 | 1408 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Ribavirin | 1 | 2018 | 1182 | 0.03 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2019 | 3776 | 0.02 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.02 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.02 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Adolescent | 4 | 2019 | 86841 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2017 | 6049 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Hemorrhage | 1 | 2017 | 3013 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Viruses | 1 | 2017 | 2238 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Ritonavir | 1 | 2018 | 4212 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Viremia | 1 | 2000 | 1020 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 13720 | 0.00 | Why? |
Lunghi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(130)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_